Here's Why The Clouds Have Lifted For Quest Diagnostics
After hitting its 52-week low in April, Quest Diagnostics (NYSE: DGX) has seen its stock recover nicely, even beating the S&P 500 year to date. This diagnostic giant has been processing many tests for COVID-19 but suffered an initial slowdown in its core testing business when the coronavirus pandemic first hit. The stock has continued climbing back up thanks to good news from the company about the recovery in its normal testing business.
But are the signs so positive that the stock is a buy? Let's find out.
Image Source: Getty Images
Source Fool.com
